ARTICLE | Financial News

Berry Genomics pursues listing via reverse merger

December 30, 2016 12:09 AM UTC

Berry Genomics Co. Ltd. (Beijing, China) will reverse-merge with auto parts company Chengdu Tianxing Instrument & Meter Co. (SZSE:000710) to form a publicly traded gene sequencing company on the Shenzhen Stock Exchange, according to a regulatory filing. The deal values Berry at RMB4.3 billion ($618.8 million), the filing said.

Berry Genomics provides sequencing and genetic testing services, including the NextSeq CN500 system to detect fetal trisomies 13, 18 and 21. The high throughput, next-generation sequencing test uses Berry’s Bambni assay and the NextSeq 500 Sequencing System from Illumina Inc. (NASDAQ:ILMN)...

BCIQ Company Profiles

Berry Genomics Co. Ltd.